Skip to content
Supplements in the Ozempic Age: Special Report 2024
Supplements in the Ozempic Age: Special Report 2024
Supplements in the Ozempic Age: Special Report 2024
Supplements in the Ozempic Age: Special Report 2024
Supplements in the Ozempic Age: Special Report 2024
Supplements in the Ozempic Age: Special Report 2024
Supplements in the Ozempic Age: Special Report 2024
Supplements in the Ozempic Age: Special Report 2024
Supplements in the Ozempic Age: Special Report 2024
Supplements in the Ozempic Age: Special Report 2024
Supplements in the Ozempic Age: Special Report 2024
Supplements in the Ozempic Age: Special Report 2024

Supplements in the Ozempic Age: Special Report 2024

$1,995.00

As the popularity of GLP-1 drugs like Ozempic continues to skyrocket, it’s more important than ever for supplement companies to understand how the weight management and blood sugar regulation markets are adapting. The Supplements in the Ozempic Age report delivers comprehensive market data, consumer insights, and strategic opportunities to help your business thrive in this dramatically-shifting environment. 

What’s Inside? 

  • Market Sizing & Growth Analysis: Get detailed data on the size and growth of the weight management and blood sugar management markets, broken down by key channels—mass market, natural and specialty, and DTC (Direct-to-Consumer). 

  • Top Ingredients for Success: Learn about the 16 most popular ingredients in weight management and blood sugar control supplements and how they can enhance product development strategies. 

  • Channel Performance: Explore sales trends and growth trajectories across multiple channels, including the growing shift toward online sales, and understand how this could impact your business. 

Exclusive Consumer Survey Data 

The report includes 62 consumer survey charts, providing unmatched insight into the behaviors and preferences of three distinct groups: 

  1. Consumers who have never taken GLP-1 drugs. 

  1. Consumers who are currently using GLP-1 drugs. 

  1. Consumers who have used GLP-1 drugs in the past but no longer do. 

These surveys shed light on how consumers perceive the relationship between supplements and GLP-1 drugs, and how these two product categories can work in synergy throughout the weight loss or blood sugar management journey. 


Subscribers receive 10% off!

Not a subscriber?

Learn More

Already a subscriber?

Email nbjsubscriptions@newhope.com for your discount

Each chapter contains action items to bring the insights into your day-to-day

For the MarketerFor the Product DeveloperFor the CEO/Executive

Over 70 Data Charts

GLP-1 Drug User Data

Raw Data + PPT Slides

Table of Contents

Download the Table of Contents

Executive overview

Before

During

After

Blood sugar management

Acknowledgments and definitions

The NBJ model pulls from myriad data sources, outlined in our Methodology. Critical to our outputs are partnerships with SPINS, which powers our retail data and understanding, and ClearCut Analytics, whose Amazon data supports our e-commerce projections.

Powered by

SPINS

Ecommerce model supported by

ClearCut Analytics

Our unique methodology tells you

  • what people are buying
  • where they're buying it
  • why they're buying it

Learn how this multi-input data model provides a comprehensive view of the industry and delivers the most accurate forecasts 

Explore Our Unique Model

Testimonials

Gaia Herbs

Director, Brand Strategy

"As a brand and product development leader in the natural products industry, I have always relied on NBJ as valuable and primary sources for credible industry data and actionable insights on emerging trends."

Megafood

Director of Marketing

"NBJ Reports are used by our Exec Team, Brand/Mktg/Sales leaders to support data-based decision making and gives us industry and competitive insights."

Native Botanicals

Owner/President

"The data and information vividly reflects the trends, challenges, regulatory impacts we have experienced as we have grown into the ‘adult-hood’ of an industry we are today"

Trusted by:

Glanbia
DSM
Lonza
NOW
Pharmavite

Featured in:

Entrepreneur
Washington Post
Consumer Reports
Fast Company
Yahoo Finance